Ann: BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS, page-324

First 324 Last

Share
Profile

Follow
Beno77

5,432 Posts.

669

26/11/21

22:56

Post #: 57896444
Share

Originally posted by gonegambler: ↑

How do you know FDA will be funding the trial?

Chances of parternship - that's what you wish. Anything is possible but you simply don't know.

Do you have a proven or safe drug or both? Not proven for anything, as of now.

Very strong evidence is such studies may or may not mean anything. A number of new molecules were beneficial in such studies but came to nothing (either received no funding or failed in human trials). The literature is littered with such molecules. So you are not certain whether it will work or not.

Remdesivir has limited but arguably proven benefit and this molecule has no proven human benefit for this virus.

Now coming to what was reported:

1. For in vitro study, what dosage would you require to get to the EC50 that is enough to inhibit replication
2. In vivo study, the dosage was 100mg/kg and 300mg/kg. Try extrapolating this to a 80kg human. What is your take on extrapolating pharmacokinetics of this mice to humans (absorption, CL, Vd, elimination kinetics etc). Safety data from prior study was on 100-200mg (not mg/kg)
3. Figure 1. Use of T-test for data that does not appear to be normally distributed, skipped SD/SEM/CI altogether
4. CIs do come up in figure 2, but not reported in numerals, SD/SEM missing
5. Same for figure 3. Guess, with n=5, reporting CIs is not in their favour
6. Only WA1 for mice study

As far as the last RCT goes, perform a critical appraisal/check with RoB 2/CONSORT. You will know why there wasn't any taker.

I wish you luck with this molecule and hope that it will not add to growing worldwide frustration with research waste. I am of firm opinion that optimism from vaccines should not deter research funding of therapeutic molecules.

Best, G

Expand

you have had 38 posts on the last 2 years with some of the biggest companies in the world.

BIT Price at posting: 8.6¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

ASX Market Open: Market to rise .5% close to record | 21 Oct 2024

There are more pages in this discussion • 163 more messages in this thread...

First 324 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change 0.000(0.00%)		Mkt cap ! $19.85M

Open	High	Low	Value	Volume
2.2¢	2.3¢	2.2¢	$8.562K	389.1K

Buyers (Bids)

No.	Vol.	Price($)
1	228	2.2¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	1991719	1

View Market Depth

No.	Vol.	Price($)
3	365000	0.021
10	916111	0.020
10	1806701	0.019
10	1719892	0.018
6	614520	0.017

Price($)	Vol.	No.
0.023	1991719	1
0.024	234999	2
0.025	150000	1
0.026	53847	1
0.027	162000	2

Last trade - 14.47pm 18/10/2024 (20 minute delay)

BIT (ASX) Chart

Ann: BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS, page-324

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Nanoveu surges 10% after benchmark testing for new AI chip begins

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

ASX Market Open: Market to rise .5% close to record | 21 Oct 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS, page-324

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Nanoveu surges 10% after benchmark testing for new AI chip begins

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

ASX Market Open: Market to rise .5% close to record | 21 Oct 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News